Aurélien Lorthioir

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

Michel Azizi, Kintur Sanghvi, Manish Saxena et al. · The Lancet · 2021 · 375 citations · Full text

Hypertension, Urology, Renal Function +9

Adherence to Antihypertensive Treatment and the Blood Pressure–Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial

Michel Azizi, Héléna Pereira, Idir Hamdidouche et al. · Circulation · 2016 · 153 citations

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

Cécile Couchoud, Florian Bayer, Carole Ayav et al. · Kidney International · 2020 · 150 citations · Full text

Hemodialysis, Medicine, Covid-19 Pandemic +9

Polycystin deficiency induces dopamine-reversible alterations in flow-mediated dilatation and vascular nitric oxide release in humans

Aurélien Lorthioir, Robinson Joannidès, Isabelle Rémy‐Jouet et al. · Kidney International · 2014 · 68 citations · Full text

Medicine, Physiology, Endothelial Dysfunction +5

The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)—clinical phenotypes and their predictors based on a cohort of 1000 patients

Marco Pappaccogli, Silvia Di Monaco, Ewa Warchoł-Celińska et al. · Cardiovascular Research · 2020 · 67 citations · Full text